Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario

被引：0
|
作者：
Iacono, D. [1 ]
Vitale, M. G. [2 ]
Cortiula, F. [2 ]
Cinausero, M. [2 ]
Tullio, A. [3 ]
Valent, F. [3 ]
Macerelli, M. [1 ]
Follador, A. [1 ]
Vogrig, A. [4 ]
Minisini, A. M. [1 ]
Puglisi, F. [2 ]
Fasola, G. [1 ]
机构：
[1] ASUIUD Santa Maria Misericordia, Dept Oncol, Udine, Italy
[2] Univ Udine, Dept Med DAME, Udine, Italy
[3] ASUIUD Santa Maria Misericordia, Hyg & Clin Epidemiol Unit, Udine, Italy
[4] ASUIUD Santa Maria Misericordia, Dept Neurosci, Udine, Italy
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1198P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Consistent Patterns of Immune-Related Adverse Events in Postmortem and Real-World Data on Immune Checkpoint Inhibitors
    Frey, Connor
    MODERN PATHOLOGY, 2025, 38 (04)
  • [2] Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis
    Yang, Yana
    Li, Linman
    Tian, Jing
    Ma, Linwen
    Wu, Yaoxin
    Luo, Qian
    Luo, Yan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [3] Rheumatic immune adverse events related to immune checkpoint inhibitors-(IrAEs related to ICI)
    Tingry, Thomas
    Massy, Emmanuel
    Piperno, Muriel
    Auroux, Maxime
    Kostine, Marie
    Maillet, Denis
    Amini-Adle, Mona
    Fabien, Nicole
    Estublier, Charline
    Goncalves, David
    Girard, Nicolas
    Confavreux, Cyrille B.
    BULLETIN DU CANCER, 2021, 108 (06) : 643 - 653
  • [4] IMMUNE-RELATED ADVERSE EVENTS FROM IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: A REAL-WORLD EXPERIENCE
    Gampa, Anuhya
    Peeraphatdit, Thoetchai
    Charlton, Michael R.
    Pillai, Anjana A.
    HEPATOLOGY, 2020, 72 : 694A - 695A
  • [5] Real-world data of immune-related adverse events in lung cancer patients receiving immune-checkpoint inhibitors
    Hu, Xiao
    Rodday, Angie Mae
    Gurinovich, Anastasia
    Pan, Stacey
    Salei, Yana V.
    Lin, Jeffrey H.
    Byrne, Margaret M.
    Cao, Yu
    Pai, Lori
    Parsons, Susan K.
    IMMUNOTHERAPY, 2025,
  • [6] Immune-related adverse events associated with checkpoint inhibitors therapy in a real world setting
    Amaral, Teresa
    Eigentler, Thomas
    Caballero, Paloma
    Tampouri, Ioanna
    Lomberg, Diana
    Assi, Zeinab
    Thomas, Ioannis
    Koechel, Ansgar
    Mueller, Alisa
    Kofler, Lukas
    Leiter, Ulrike
    Forschner, Andrea
    Garbe, Claus
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
  • [7] Real-world usage and adverse events (AE) of immune checkpoint inhibitors (ICI): A large-scale, automated, GDPRcompliant analysis of hospital records
    Verbiest, A. T. L.
    Debruyne, P. R.
    Bassez, I.
    Delombaerde, D. L.
    Tack, L.
    Oeste, C. L.
    Deckx, L.
    Croes, L.
    Hens, D. F. E.
    Geldhof, V.
    Prenen, H.
    Vulsteke, C.
    ANNALS OF ONCOLOGY, 2024, 35 : S702 - S703
  • [8] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Li Zhong
    Qing Wu
    Fuchun Chen
    Junjin Liu
    Xianhe Xie
    Cancer Immunology, Immunotherapy, 2021, 70 : 2559 - 2576
  • [9] Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
    Zhong, Li
    Wu, Qing
    Chen, Fuchun
    Liu, Junjin
    Xie, Xianhe
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (09) : 2559 - 2576
  • [10] Predictors of immune checkpoint inhibitor-related adverse events in older patients with lung cancer: a prospective real-world analysis
    Gao, Jiayi
    Zhang, Ping
    Tang, Min
    Nie, Xin
    Yuan, Yue
    Yang, Fan
    Li, Lin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 8993 - 9006
12345